Sven H. Borho
@Orbimed Advisors Llc
Latest period2024 - Q3ReportedManaged Assets$5.504BTotal holdings113
Assets growth rate8.67%Assets growth rate (2-Q avg)0.72%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Orbimed Advisors Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 113 positions.
Assets under management
The assets under management (AUM) of Orbimed Advisors Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 5.504B in assets, with a quarterly growth rate of 8.67% and a 2-quarter average growth rate of 0.72%. The portfolio is managed by Sven H. Borho, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
SYKStryker Corporation
| 2.27% | $124.418M 344,400 shares@ $361.26 avg price | Increased 28.03% |
SPRYArs Pharmaceuticals Inc
| 2.19% | $120.183M 8.289M shares@ $14.5 avg price | Decreased -10.3% |
ARGXArgenx Se
| 2.02% | $110.855M 204,500 shares@ $542.08 avg price | Decreased -2.19% |
UNHUnitedhealth Group Inc
| 1.91% | $104.658M 179,000 shares@ $584.68 avg price | Increased 59.83% |
QTTBQ32 Bio Inc
| 1.83% | $100.528M 2.253M shares@ $44.63 avg price | |
MBXMbx Biosciences Inc
| 1.8% | $99.041M 3.812M shares@ $25.99 avg price | New Position |
IONSIonis Pharmaceuticals Inc
| 1.7% | $93.117M 2.324M shares@ $40.07 avg price | Decreased -2.01% |
IRONDisc Medicine Inc
| 1.6% | $87.743M 1.786M shares@ $49.15 avg price | |
NTRANatera Inc
| 1.59% | $87.278M 687,500 shares@ $126.95 avg price | |
AMGNAmgen Inc
| 1.48% | $81.294M 252,300 shares@ $322.21 avg price | Increased 87.03% |